Persistence Market Research Company
Customize Now Get FREE Sample

Pharmacovigilance Market Size, Share, Growth, and Regional Forecast, 2026 to 2033

Pharmacovigilance Market by Reporting Type (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining), Deployment Mode (In-house, Contract Outsourcing), Product Life Cycle (Pre-clinical, Phase I, Phase II, Phase III, Phase IV), Therapeutic Area (Oncology, Neurology, Infectious Diseases, Cardiology, Respiratory Systems, Others), End-user, and Regional Analysis from 2026 to 2033

ID: PMRREP36214| 188 Pages | 24 Feb 2026 | Format: PDF, Excel, PPT* | Healthcare

Market Growth and Regional Outlook Report by Persistence Market Research

Table of Content

  1. Executive Summary
    1. Global Pharmacovigilance Market Snapshot, 2026 and 2033
    2. Market Opportunity Assessment, 2026 - 2033, US$ Bn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
    3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors - Relevance and Impact
  3. Value Added Insights
    1. Regulatory Landscape
    2. Product Adoption Analysis
    3. Value Chain Analysis
    4. Key Deals and Mergers
    5. PESTLE Analysis
    6. Porter’s Five Force Analysis
  4. Global Pharmacovigilance Market Outlook:
    1. Key Highlights
      1. Market Size (US$ Bn) and Y-o-Y Growth
      2. Absolute $ Opportunity
    2. Market Size (US$ Bn) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2020-2025
      2. Market Size (US$ Bn) Analysis and Forecast, 2026-2033
    3. Global Pharmacovigilance Market Outlook: Type
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Type, 2020 - 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By Type, 2026 - 2033
        1. Spontaneous Reporting
        2. Intensified ADR Reporting
        3. Targeted Spontaneous Reporting
        4. Cohort Event Monitoring
        5. EHR Mining
      4. Market Attractiveness Analysis: Type
    4. Global Pharmacovigilance Market Outlook: Deployment Mode
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Deployment Mode, 2020 - 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By Deployment Mode, 2026 - 2033
        1. In-house
        2. Contract Outsourcing
      4. Market Attractiveness Analysis: Deployment Mode
    5. Global Pharmacovigilance Market Outlook: Product Life Cycle
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Product Life Cycle, 2020 - 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By Product Life Cycle, 2026 - 2033
        1. Pre-clinical
        2. Phase I
        3. Phase II
        4. Phase III
        5. Phase IV
      4. Market Attractiveness Analysis: Product Life Cycle
    6. Global Pharmacovigilance Market Outlook: Therapeutic Area
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Therapeutic Area, 2020 - 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2026 - 2033
        1. Oncology
        2. Neurology
        3. Infectious Diseases
        4. Cardiology
        5. Respiratory Systems
        6. Others
      4. Market Attractiveness Analysis: Therapeutic Area
    7. Global Pharmacovigilance Market Outlook: End User
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By End User, 2020 - 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
        1. Pharmaceutical Companies
        2. Contract Research Organizations (CROs)
        3. Biotechnology Firms
        4. Medical Device & Combination Product Manufacturers
        5. Others
      4. Market Attractiveness Analysis: End User
  5. Global Pharmacovigilance Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Region, 2020 - 2025
    3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2026 - 2033
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  6. North America Pharmacovigilance Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Type
      3. By Deployment Mode
      4. By Product Life Cycle
      5. By Therapeutic Area
      6. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. U.S.
      2. Canada
    4. Market Size (US$ Bn) Analysis and Forecast, By Type, 2026 - 2033
      1. Spontaneous Reporting
      2. Intensified ADR Reporting
      3. Targeted Spontaneous Reporting
      4. Cohort Event Monitoring
      5. EHR Mining
    5. Market Size (US$ Bn) Analysis and Forecast, By Deployment Mode, 2026 - 2033
      1. In-house
      2. Contract Outsourcing
    6. Market Size (US$ Bn) Analysis and Forecast, By Product Life Cycle, 2026 - 2033
      1. Pre-clinical
      2. Phase I
      3. Phase II
      4. Phase III
      5. Phase IV
    7. Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2026 - 2033
      1. Oncology
      2. Neurology
      3. Infectious Diseases
      4. Cardiology
      5. Respiratory Systems
      6. Others
    8. Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2026 - 2033
      1. Pharmaceutical Companies
      2. Contract Research Organizations (CROs)
      3. Biotechnology Firms
      4. Medical Device & Combination Product Manufacturers
      5. Others
    9. Market Attractiveness Analysis
  7. Europe Pharmacovigilance Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Type
      3. By Deployment Mode
      4. By Product Life Cycle
      5. By Therapeutic Area
      6. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
    4. Market Size (US$ Bn) Analysis and Forecast, By Type, 2026 - 2033
      1. Spontaneous Reporting
      2. Intensified ADR Reporting
      3. Targeted Spontaneous Reporting
      4. Cohort Event Monitoring
      5. EHR Mining
    5. Market Size (US$ Bn) Analysis and Forecast, By Deployment Mode, 2026 - 2033
      1. In-house
      2. Contract Outsourcing
    6. Market Size (US$ Bn) Analysis and Forecast, By Product Life Cycle, 2026 - 2033
      1. Pre-clinical
      2. Phase I
      3. Phase II
      4. Phase III
      5. Phase IV
    7. Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2026 - 2033
      1. Oncology
      2. Neurology
      3. Infectious Diseases
      4. Cardiology
      5. Respiratory Systems
      6. Others
    8. Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2026 - 2033
      1. Pharmaceutical Companies
      2. Contract Research Organizations (CROs)
      3. Biotechnology Firms
      4. Medical Device & Combination Product Manufacturers
      5. Others
    9. Market Attractiveness Analysis
  8. East Asia Pharmacovigilance Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Type
      3. By Deployment Mode
      4. By Product Life Cycle
      5. By Therapeutic Area
      6. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. China
      2. Japan
      3. South Korea
    4. Market Size (US$ Bn) Analysis and Forecast, By Type, 2026 - 2033
      1. Spontaneous Reporting
      2. Intensified ADR Reporting
      3. Targeted Spontaneous Reporting
      4. Cohort Event Monitoring
      5. EHR Mining
    5. Market Size (US$ Bn) Analysis and Forecast, By Deployment Mode, 2026 - 2033
      1. In-house
      2. Contract Outsourcing
    6. Market Size (US$ Bn) Analysis and Forecast, By Product Life Cycle, 2026 - 2033
      1. Pre-clinical
      2. Phase I
      3. Phase II
      4. Phase III
      5. Phase IV
    7. Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2026 - 2033
      1. Oncology
      2. Neurology
      3. Infectious Diseases
      4. Cardiology
      5. Respiratory Systems
      6. Others
    8. Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2026 - 2033
      1. Pharmaceutical Companies
      2. Contract Research Organizations (CROs)
      3. Biotechnology Firms
      4. Medical Device & Combination Product Manufacturers
      5. Others
    9. Market Attractiveness Analysis
  9. South Asia & Oceania Pharmacovigilance Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Type
      3. By Deployment Mode
      4. By Product Life Cycle
      5. By Therapeutic Area
      6. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Market Size (US$ Bn) Analysis and Forecast, By Type, 2026 - 2033
      1. Spontaneous Reporting
      2. Intensified ADR Reporting
      3. Targeted Spontaneous Reporting
      4. Cohort Event Monitoring
      5. EHR Mining
    5. Market Size (US$ Bn) Analysis and Forecast, By Deployment Mode, 2026 - 2033
      1. In-house
      2. Contract Outsourcing
    6. Market Size (US$ Bn) Analysis and Forecast, By Product Life Cycle, 2026 - 2033
      1. Pre-clinical
      2. Phase I
      3. Phase II
      4. Phase III
      5. Phase IV
    7. Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2026 - 2033
      1. Oncology
      2. Neurology
      3. Infectious Diseases
      4. Cardiology
      5. Respiratory Systems
      6. Others
    8. Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2026 - 2033
      1. Pharmaceutical Companies
      2. Contract Research Organizations (CROs)
      3. Biotechnology Firms
      4. Medical Device & Combination Product Manufacturers
      5. Others
    9. Market Attractiveness Analysis
  10. Latin America Pharmacovigilance Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Type
      3. By Deployment Mode
      4. By Product Life Cycle
      5. By Therapeutic Area
      6. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Market Size (US$ Bn) Analysis and Forecast, By Type, 2026 - 2033
      1. Spontaneous Reporting
      2. Intensified ADR Reporting
      3. Targeted Spontaneous Reporting
      4. Cohort Event Monitoring
      5. EHR Mining
    5. Market Size (US$ Bn) Analysis and Forecast, By Deployment Mode, 2026 - 2033
      1. In-house
      2. Contract Outsourcing
    6. Market Size (US$ Bn) Analysis and Forecast, By Product Life Cycle, 2026 - 2033
      1. Pre-clinical
      2. Phase I
      3. Phase II
      4. Phase III
      5. Phase IV
    7. Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2026 - 2033
      1. Oncology
      2. Neurology
      3. Infectious Diseases
      4. Cardiology
      5. Respiratory Systems
      6. Others
    8. Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2026 - 2033
      1. Pharmaceutical Companies
      2. Contract Research Organizations (CROs)
      3. Biotechnology Firms
      4. Medical Device & Combination Product Manufacturers
      5. Others
    9. Market Attractiveness Analysis
  11. Middle East & Africa Pharmacovigilance Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Type
      3. By Deployment Mode
      4. By Product Life Cycle
      5. By Therapeutic Area
      6. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Market Size (US$ Bn) Analysis and Forecast, By Type, 2026 - 2033
      1. Spontaneous Reporting
      2. Intensified ADR Reporting
      3. Targeted Spontaneous Reporting
      4. Cohort Event Monitoring
      5. EHR Mining
    5. Market Size (US$ Bn) Analysis and Forecast, By Deployment Mode, 2026 - 2033
      1. In-house
      2. Contract Outsourcing
    6. Market Size (US$ Bn) Analysis and Forecast, By Product Life Cycle, 2026 - 2033
      1. Pre-clinical
      2. Phase I
      3. Phase II
      4. Phase III
      5. Phase IV
    7. Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2026 - 2033
      1. Oncology
      2. Neurology
      3. Infectious Diseases
      4. Cardiology
      5. Respiratory Systems
      6. Others
    8. Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2026 - 2033
      1. Pharmaceutical Companies
      2. Contract Research Organizations (CROs)
      3. Biotechnology Firms
      4. Medical Device & Combination Product Manufacturers
      5. Others
    9. Market Attractiveness Analysis
  12. Competition Landscape
    1. Market Share Analysis, 2025
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
      1. IQVIA
        1. Overview
        2. Segments and Products
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Wipro
      3. ICON plc.
      4. ArisGlobal
      5. Accenture
      6. ClinChoice (formerly FMD K&L)
      7. IBM
      8. TAKE Solutions Ltd.
      9. Cognizant
      10. United BioSource LLC
      11. Capgemini
      12. Laboratory Corporation of America Holdings
      13. ITClinical
      14. PAREXEL International Corporation
      15. BioClinica Inc. (Clario)
      16. Clinquest Group B.V. (Linical Americas)
      17. Others
  13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
We use cookies to improve user experience.
Google translate